The tariff classification of Swift Ankle-Foot Orthosis from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the Swift AFO will be 9021.10.0090, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Orthopedic appliances …: Orthopedic or fracture appliances, and parts and accessories thereof: Other.” The general rate of duty will be free.
Ruling text
In your letter dated October 14, 2026, you requested a tariff classification ruling. The Elevate Swift Ankle-Foot Orthosis (AFO) is a custom-fabricated dorsiflexion-assist ankle-foot orthosis that supports the foot and ankle positions of individuals unable to do so independently because of foot drop and reduced dorsiflexion. It comprises a custom carbon fiber strut, a heat-moldable footplate, a heat-moldable calf cuff, a heat-moldable inner boot, a BOA® Fit System calf strap, a CoolFlow liner, and a HelixBand.
The HelixBand provides medial-lateral and rotational (varus/valgus) control, allowing the clinician to customize the Swift for patients whose foot drop is accompanied by coronal-plane instability. The heat-moldable footplate, calf cuff, and inner boot are trimmed and thermoformed to each individual patient during fitting. The components are imported together in disassembled form, along with product labeling, instructions for use, a patient care and rehabilitation guide, warnings, and warranty information, as a kit.
The Swift AFO is offered in two designs, posterior and anterior, each available in right- and left-foot models, for a total of four configurations. The Swift posterior design is indicated for foot drop with medial-lateral instability, and the Swift anterior design is indicated for foot drop with medial-lateral instability accompanied by knee instability or quadriceps weakness.
You state that the Swift AFO is designed for the benefit of people with foot drop, a permanent or chronic condition that limits a patient’s physical mobility. It is a specially designed, custom-fabricated ambulatory aid engineered to assist individuals with mobility impairments caused by foot drop. Any other use is speculative and fugitive. The Swift AFO lifts the front of the foot through dorsiflexion assistance, enabling the foot to achieve adequate ground clearance during the swing phase of walking.
The result is a more natural gait and a reduced risk of trips and falls. The Swift AFO’s carbon fiber footplate limits excessive downward movement of the forefoot (plantar flexion) while managing weight distribution and energy transfer during walking. Its carbon fiber strut delivers dynamic ground reaction forces and connects the footplate to the calf cuff to enhance stability while supporting the tibia.
The HelixBand provides medial-lateral and rotational control for patients whose foot drop is accompanied by coronal-plane instability, and the heat-moldable footplate, calf cuff, and inner boot are custom-thermoformed to the individual patient. The calf cuff and BOA strap secure the AFO to the upper lower leg, ensuring a proper fit and providing the prescribed dorsiflexion and medial-lateral support, while the CoolFlow liner enhances comfort to support extended wear.
You explain that the product’s physical properties are not useful to the general public. The design, form, and corresponding use of the Swift AFO, particularly its custom fabrication to an individual patient’s limb geometry, clearly designate it as an article designed to address the symptoms of foot drop and provide no benefit to non-handicapped persons.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N366043).